vs
STANDARD BIOTOOLS INC.（LAB）与Tectonic Financial, Inc.（TECTP）财务数据对比。点击上方公司名可切换其他公司
Tectonic Financial, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$23.0M vs $19.6M），Tectonic Financial, Inc.净利率更高（23.8% vs -177.4%，领先201.3%），Tectonic Financial, Inc.同比增速更快（17.9% vs -11.5%），Tectonic Financial, Inc.自由现金流更多（$-17.3M vs $-23.1M），过去两年Tectonic Financial, Inc.的营收复合增速更高（270.5% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Tectonic Financial, Inc.是一家总部位于美国的多元化金融服务提供商，核心业务涵盖财富管理、投资银行、资本市场咨询等领域，服务对象包括高净值人群、机构投资者及北美地区的中小型企业。
LAB vs TECTP — 直观对比
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $23.0M |
| 净利润 | $-34.7M | $5.5M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 30.6% |
| 净利率 | -177.4% | 23.8% |
| 营收同比 | -11.5% | 17.9% |
| 净利润同比 | -28.8% | 15.9% |
| 每股收益（稀释后） | $-0.09 | $0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q3 25 | $19.6M | $23.0M | ||
| Q2 25 | $21.8M | $21.6M | ||
| Q1 25 | $40.8M | $21.8M | ||
| Q4 24 | — | $21.4M | ||
| Q3 24 | $22.1M | $19.5M | ||
| Q2 24 | $22.5M | $18.6M | ||
| Q1 24 | $45.5M | $17.6M | ||
| Q4 23 | $28.2M | $1.7M |
| Q3 25 | $-34.7M | $5.5M | ||
| Q2 25 | $-33.5M | $4.3M | ||
| Q1 25 | $-26.0M | $4.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-26.9M | $4.7M | ||
| Q2 24 | $-45.7M | $3.1M | ||
| Q1 24 | $-32.2M | $3.1M | ||
| Q4 23 | $-19.8M | $3.3M |
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — | ||
| Q4 23 | 47.6% | — |
| Q3 25 | -168.5% | 30.6% | ||
| Q2 25 | -118.1% | 25.9% | ||
| Q1 25 | -80.8% | 26.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | -120.9% | 29.1% | ||
| Q2 24 | -134.5% | 21.5% | ||
| Q1 24 | -132.2% | 22.2% | ||
| Q4 23 | -75.9% | — |
| Q3 25 | -177.4% | 23.8% | ||
| Q2 25 | -153.7% | 19.8% | ||
| Q1 25 | -63.8% | 20.4% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | -122.0% | 24.2% | ||
| Q2 24 | -203.3% | 16.9% | ||
| Q1 24 | -70.6% | 17.4% | ||
| Q4 23 | -70.2% | 197.4% |
| Q3 25 | $-0.09 | $0.73 | ||
| Q2 25 | $-0.09 | $0.55 | ||
| Q1 25 | $-0.07 | $0.57 | ||
| Q4 24 | — | $0.35 | ||
| Q3 24 | $-0.07 | $0.58 | ||
| Q2 24 | $-0.12 | $0.38 | ||
| Q1 24 | $-0.27 | $0.37 | ||
| Q4 23 | $-0.24 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $119.2M |
| 总资产 | $539.6M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — | ||
| Q4 23 | $51.7M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — | ||
| Q4 23 | $63.5M | — |
| Q3 25 | $399.7M | $119.2M | ||
| Q2 25 | $424.5M | $114.6M | ||
| Q1 25 | $454.6M | $111.3M | ||
| Q4 24 | — | $113.4M | ||
| Q3 24 | $489.3M | $112.8M | ||
| Q2 24 | $510.3M | $110.4M | ||
| Q1 24 | $577.3M | $108.5M | ||
| Q4 23 | $-148.1M | $106.9M |
| Q3 25 | $539.6M | $1.1B | ||
| Q2 25 | $557.0M | $997.0M | ||
| Q1 25 | $579.6M | $910.5M | ||
| Q4 24 | — | $863.4M | ||
| Q3 24 | $681.5M | $847.5M | ||
| Q2 24 | $708.7M | $777.1M | ||
| Q1 24 | $777.7M | $777.6M | ||
| Q4 23 | $323.1M | $677.3M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-17.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-17.3M |
| 自由现金流率自由现金流/营收 | -118.1% | -74.9% |
| 资本支出强度资本支出/营收 | 4.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | -3.14× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
| Q3 25 | $-22.2M | $-17.3M | ||
| Q2 25 | $-20.7M | $-32.5M | ||
| Q1 25 | $-30.3M | $-35.6M | ||
| Q4 24 | — | $-86.6M | ||
| Q3 24 | $-27.9M | $-22.5M | ||
| Q2 24 | $-39.0M | $-30.7M | ||
| Q1 24 | $-62.5M | $-3.2M | ||
| Q4 23 | $-14.1M | $-16.7M |
| Q3 25 | $-23.1M | $-17.3M | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | $-35.6M | ||
| Q4 24 | — | $-86.8M | ||
| Q3 24 | $-30.1M | $-22.5M | ||
| Q2 24 | $-41.0M | $-30.7M | ||
| Q1 24 | $-63.3M | $-3.3M | ||
| Q4 23 | $-14.1M | $-16.7M |
| Q3 25 | -118.1% | -74.9% | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | -163.2% | ||
| Q4 24 | — | -406.5% | ||
| Q3 24 | -136.4% | -115.0% | ||
| Q2 24 | -182.2% | -165.5% | ||
| Q1 24 | -138.9% | -18.8% | ||
| Q4 23 | -50.2% | -996.2% |
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 12.4% | 0.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | 10.2% | 0.1% | ||
| Q2 24 | 8.6% | 0.3% | ||
| Q1 24 | 1.7% | 0.9% | ||
| Q4 23 | 0.3% | 0.4% |
| Q3 25 | — | -3.14× | ||
| Q2 25 | — | -7.61× | ||
| Q1 25 | — | -8.00× | ||
| Q4 24 | — | -28.99× | ||
| Q3 24 | — | -4.74× | ||
| Q2 24 | — | -9.76× | ||
| Q1 24 | — | -1.03× | ||
| Q4 23 | — | -5.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
TECTP
暂无分部数据
